{"id":"https://openalex.org/W2248129227","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.3039","title":"Pharmacokinetics (PK) and pharmacodynamics (PD) of RG7112, an oral murine double minute 2 (MDM2) antagonist, in patients with leukemias and solid tumors.","display_name":"Pharmacokinetics (PK) and pharmacodynamics (PD) of RG7112, an oral murine double minute 2 (MDM2) antagonist, in patients with leukemias and solid tumors.","publication_year":2011,"publication_date":"2011-05-20","ids":{"openalex":"https://openalex.org/W2248129227","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.3039","mag":"2248129227"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2011.29.15_suppl.3039","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.3039","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2011.29.15_suppl.3039","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075068111","display_name":"Anna Beryozkina","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Beryozkina","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074661473","display_name":"GWEN L. NICHOLS","orcid":"https://orcid.org/0000-0002-3714-4927","observed_orcids":["https://orcid.org/0000-0002-3714-4927"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. L. Nichols","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054318500","display_name":"Monica Reckner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Reckner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046690523","display_name":"Lyubomir T. Vassilev","orcid":"https://orcid.org/0000-0002-5557-0671","observed_orcids":["https://orcid.org/0000-0002-5557-0671"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. T. Vassilev","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084978897","display_name":"Ruediger Rueger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Rueger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074300648","display_name":"Lori Jukofsky","orcid":"https://orcid.org/0000-0001-7036-8431","observed_orcids":["https://orcid.org/0000-0001-7036-8431"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Jukofsky","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"S. Middleton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Middleton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110692113","display_name":"Micheal Andreeff","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Andreeff","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"S. Padmanabhan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Padmanabhan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019788466","display_name":"ROGER K. STRAIR","orcid":"https://orcid.org/0000-0002-1881-7989","observed_orcids":["https://orcid.org/0000-0002-1881-7989"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Strair","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003640697","display_name":"Maria L. Delioukina","orcid":"https://orcid.org/0009-0005-6827-7502","observed_orcids":["https://orcid.org/0009-0005-6827-7502"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. L. Delioukina","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077735185","display_name":"Peter George Maslak","orcid":"https://orcid.org/0000-0003-1949-5819","observed_orcids":["https://orcid.org/0000-0003-1949-5819"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. G. Maslak","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047631289","display_name":"Peter Hillmen","orcid":"https://orcid.org/0000-0001-5617-4403","observed_orcids":["https://orcid.org/0000-0001-5617-4403"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Hillmen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053481267","display_name":"Razelle Kurzrock","orcid":"https://orcid.org/0000-0003-4110-1214","observed_orcids":["https://orcid.org/0000-0003-4110-1214"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Kurzrock","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037169725","display_name":"Lia Gore","orcid":"https://orcid.org/0000-0002-2546-4616","observed_orcids":["https://orcid.org/0000-0002-2546-4616"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Gore","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070570779","display_name":"Amita Patnaik","orcid":"https://orcid.org/0000-0002-4144-2193","observed_orcids":["https://orcid.org/0000-0002-4144-2193"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Patnaik","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068677359","display_name":"Robert G. Maki","orcid":"https://orcid.org/0000-0002-9853-2528","observed_orcids":["https://orcid.org/0000-0002-9853-2528"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. G. Maki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112040770","display_name":"G. K. Schwartz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. K. Schwartz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"A. J. Wagner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. J. Wagner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5049296452","display_name":"Jianguo Zhi","orcid":"https://orcid.org/0000-0001-5837-4687","observed_orcids":["https://orcid.org/0000-0001-5837-4687"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Zhi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"29","issue":"15_suppl","first_page":"3039","last_page":"3039"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rg7112","display_name":"RG7112","score":0.9769999980926514},{"id":"https://openalex.org/keywords/mdm2-inhibitors","display_name":"MDM2 inhibitors","score":0.8989999890327454},{"id":"https://openalex.org/keywords/p53-activation","display_name":"p53 activation","score":0.9549999833106995},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8600000143051147},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9890000224113464},{"id":"https://openalex.org/keywords/mic-1","display_name":"MIC-1","score":0.9300000071525574},{"id":"https://openalex.org/keywords/leukemia","display_name":"leukemia","score":0.7390000224113464},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.9729999899864197},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.8740000128746033},{"id":"https://openalex.org/keywords/acute-lymphoblastic-leukemia","display_name":"acute lymphoblastic leukemia","score":0.9290000200271606},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9879999756813049},{"id":"https://openalex.org/keywords/refractory-lymphoma","display_name":"refractory lymphoma","score":0.8539999723434448},{"id":"https://openalex.org/keywords/dose-proportionality","display_name":"dose proportionality","score":0.7400000095367432},{"id":"https://openalex.org/keywords/interpatient-variability","display_name":"interpatient variability","score":0.7350000143051147},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.5090000033378601},{"id":"https://openalex.org/keywords/phase-i","display_name":"phase I","score":0.5559999942779541}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8324642181396484},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.8202344179153442},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8105604648590088},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7150908708572388},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.6843334436416626},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.5620915293693542},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5321480631828308},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4542272090911865},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3719761371612549},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.28016015887260437},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2011.29.15_suppl.3039","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.3039","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2011.29.15_suppl.3039","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.800000011920929,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2504451653","https://openalex.org/W2600173499","https://openalex.org/W2182708897","https://openalex.org/W2567917900","https://openalex.org/W2048094749","https://openalex.org/W2570629397","https://openalex.org/W2186394622","https://openalex.org/W4389244371","https://openalex.org/W2596696390","https://openalex.org/W1978978593"],"abstract_inverted_index":{"3039":[0],"Background:":[1],"RG7112":[2,35,59,100,181,258,291,311],"is":[3],"a":[4,44,198,270],"selective":[5],"inhibitor":[6],"of":[7,31,47,58,121,282,309],"p53-MDM2":[8],"binding":[9],"and":[10,28,37,73,79,84,94,131,140,142,156,165,170,194,212,263,294,300,330],"frees":[11],"p53":[12,18,48,318],"from":[13,53,253,257,284,307],"negative":[14],"control,":[15],"activating":[16],"the":[17,152,220,317,322],"pathway":[19],"in":[20,60,67,106,176,219,234,279,296,326],"cancer":[21],"cells":[22],"leading":[23],"to":[24,133,158,231,240],"cell":[25],"cycle":[26,177],"arrest":[27],"apoptosis.":[29],"Results":[30],"clinical":[32,85],"PK":[33,126,154,169,207,228],"(plasma":[34,209],"concentrations)":[36],"PD":[38,171,273,314],"(serum":[39],"macrophage":[40],"inhibitory":[41],"cytokine-1,":[42],"MIC-1,":[43],"potential":[45,271],"indicator":[46],"activation)":[49],"are":[50,87],"reported":[51,88],"here":[52],"two":[54],"phase":[55,69],"1":[56,139,164,267],"studies":[57],"patients":[61,235],"(pts)":[62],"with":[63,75,197,236,242,289,298,328],"AML,":[64],"ALL,":[65],"CML":[66],"blast":[68],"or":[70,103],"refractory":[71,80],"CLL/SCLL,":[72],"pts":[74,93,98,297,327],"advanced":[76],"solid":[77,96,237,301,331],"tumors":[78,238],"lymphomas.":[81],"Safety,":[82],"tolerability,":[83],"responses":[86],"separately.":[89],"Methods:":[90],"49":[91],"leukemia":[92],"76":[95],"tumor":[97],"took":[99],"tablets":[101],"once":[102],"twice":[104],"daily":[105],"escalating":[107],"oral":[108],"doses":[109,259],"(20":[110],"\u2013":[111],"1920":[112],"mg/m2/day)":[113],"for":[114,316],"10":[115,141,193],"days":[116,120],"followed":[117],"by":[118],"18":[119],"rest":[122],"between":[123],"cycles.":[124],"Serial":[125],"samples":[127,148,172],"were":[128,149,173,251],"drawn":[129],"pre-dose":[130,143],"up":[132,157],"120":[134],"hours":[135],"post-dose":[136,187],"on":[137,144,162,191],"Days":[138,163],"Day":[145,192],"5.":[146],"MIC-1":[147,249,280,320],"collected":[150],"at":[151,188,244],"anticipated":[153],"Cmax":[155],"48-hr":[159],"post-":[160],"dose":[161,221,246,323],"10.":[166],"Limited":[167],"confirmatory":[168],"also":[174],"taken":[175],"2.":[178],"Results:":[179],"Plasma":[180],"concentrations":[182,265,292],"peaked":[183],"~":[184,203,215],"4":[185],"hr":[186],"steady-state":[189],"(SS)":[190],"then":[195],"declined":[196],"mean":[199],"terminal":[200],"elimination":[201],"t1/2":[202],"1.5":[204],"days.":[205],"The":[206,277],"exposure":[208,229],"Ctrough,":[210],"Cmax,":[211],"AUC)":[213],"was":[214,226,286],"dose-proportional":[216],"without":[217],"accumulation":[218],"range":[222,324],"studied.":[223],"Inter-patient":[224],"variability":[225],"~70%;":[227],"tended":[230],"be":[232],"higher":[233],"compared":[239],"those":[241],"leukemias":[243,299,329],"comparable":[245],"levels.":[247],"Serum":[248],"levels":[250],"elevated":[252],"individual":[254],"baseline":[255],"starting":[256],">":[260,266],"320":[261],"mg/m2":[262],"plasma":[264,290],"\u00b5g/mL,":[268],"suggesting":[269],"mechanistic":[272],"relationship":[274],"(p53":[275],"activation).":[276],"increase":[278],"(%":[281],"change":[283],"baseline)":[285],"highly":[287],"associated":[288],"(R=0.60":[293],"0.80":[295],"tumors,":[302],"respectively).":[303],"Conclusions:":[304],"As":[305],"expected":[306],"mechanism":[308],"action,":[310],"exhibited":[312],"exposure-related":[313],"response":[315],"biomarker":[319],"within":[321],"tested":[325],"tumors.":[332]},"counts_by_year":[{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-06-24T00:00:00"}